Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
Amazon
AMZN
|
+$606M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
AT&T
T
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.41B |
| 2 |
Comcast
CMCSA
|
+$658M |
| 3 |
Boston Scientific
BSX
|
+$650M |
| 4 |
Palo Alto Networks
PANW
|
+$642M |
| 5 |
T-Mobile US
TMUS
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.81% |
| 2 | Healthcare | 2.95% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12501
CALL
Cerus
CERS
$601M
| $20.7K | ﹤0.01% |
9,600
-2,900
| -23% | -$4.78K |
|
12502
AdvisorShares Pure Cannabis ETF
YOLO
$32.3M
| $20.7K | ﹤0.01% |
6,859
-2,600
| -27% | -$7.57K |
|
12503
CALL
Saratoga Investment
SAR
$304M
| $20.7K | ﹤0.01% |
800
-10,700
| -93% | -$267K |
|
12504
CALL
Karyopharm Therapeutics
KPTI
$45.8M
| $20.7K | ﹤0.01% |
1,593
+540
| +51% | +$7.28K |
|
|
ROVR
12505
CALL
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $20.7K | ﹤0.01% |
1,900
+900
| +90% | +$7.61K |
|
12506
PUT
Limoneira
LMNR
$251M
| $20.6K | ﹤0.01% |
+1,000
| New | +$16.2K |
|
12507
CALL
Procure Space ETF
UFO
$634M
| $20.5K | ﹤0.01% |
+1,100
| New | +$18K |
|
12508
CALL
Enlivex Ltd
ENLV
$26.6M
| $20.5K | ﹤0.01% |
507
+407
| +407% | +$10.4K |
|
12509
Bridgeline Digital
BLIN
$12.6M
| $20.5K | ﹤0.01% |
23,712
-12,976
| -35% | -$9.98K |
|
|
CHRN
12510
PUT
ChronoScale Holdings
CHRN
$3.04B
| $20.5K | ﹤0.01% |
547
+534
| +4,108% | +$10.1K |
|
12511
CALL
Flotek Industries
FTK
$1.3B
| $20.4K | ﹤0.01% |
5,212
+3,359
| +181% | +$13.1K |
|
12512
CALL
AngioDynamics
ANGO
$655M
| $20.4K | ﹤0.01% |
2,600
+1,900
| +271% | +$13.2K |
|
12513
CALL
MeiraGTx Holdings
MGTX
$1.3B
| $20.4K | ﹤0.01% |
2,900
-11,400
| -80% | -$56.3K |
|
|
MITT
12514
PUT
TPG Mortgage Investment Trust
MITT
$215M
| $20.4K | ﹤0.01% |
3,206
-20,494
| -86% | -$111K |
|
12515
5E Advanced Materials
FEAM
$66.8M
| $20.2K | ﹤0.01% |
+623
| New | +$30.3K |
|
|
BCLI
12516
CALL
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $20.2K | ﹤0.01% |
4,933
-3,667
| -43% | -$11K |
|
12517
PUT
State Street SPDR Portfolio Europe ETF
SPEU
$743M
| $20.2K | ﹤0.01% |
500
-100
| -17% | -$3.73K |
|
12518
CALL
PMV Pharmaceuticals
PMVP
$67.2M
| $20.1K | ﹤0.01% |
6,500
-7,100
| -52% | -$18.8K |
|
12519
Imunon
IMNN
$9.26M
| $20.1K | ﹤0.01% |
2,271
-1,169
| -34% | -$14.3K |
|
12520
China Pharma Holdings
CPHI
$45.8M
| $20.1K | ﹤0.01% |
+3,324
| New | +$18.6K |
|
12521
CALL
Westwood Holdings Group
WHG
$186M
| $20.1K | ﹤0.01% |
+1,600
| New | +$16.9K |
|
|
INZY
12522
CALL
DELISTED
Inozyme Pharma
INZY
| $20K | ﹤0.01% |
4,700
-21,000
| -82% | -$74.6K |
|
12523
CALL
Planet Labs
PL
$8.8B
| $20K | ﹤0.01% |
8,100
+7,500
| +1,250% | +$17.7K |
|
|
SLI
12524
PUT
Standard Lithium
SLI
$587M
| $20K | ﹤0.01% |
9,900
+4,300
| +77% | +$10.7K |
|
|
REVG
12525
PUT
DELISTED
REV Group
REVG
| $20K | ﹤0.01% |
1,100
-1,000
| -48% | -$16K |
|
Similar funds
Ken Griffin's Q4 2023 Portfolio in Review
As of Q4 2023, Ken Griffin held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $25.4B in Q4 2023, closing 1,624 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.
- Ken Griffin's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
- Ken Griffin's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
- Ken Griffin fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
- Ken Griffin's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
- Ken Griffin opened 1,585 new positions and closed 1,624 in Q4 2023.
- Ken Griffin's portfolio value rose 7.2% quarter-over-quarter to $500B.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.